Skip to main content

AHA 2025 Guidelines: Dyslipidemia


Management of Dyslipidemia

1. Risk Stratification (Foundation)


Management is driven by overall cardiovascular risk rather than LDL alone


Major risk categories:


Established ASCVD (very high risk)


Diabetes mellitus


Severe hypercholesterolemia (LDL ≥190 mg/dL)


Primary prevention based on risk calculators




---


2. Lifestyle Modification (First-line for all)


Diet


Reduce saturated & trans fats


Increase fiber (fruits, vegetables, whole grains)


Mediterranean/DASH-style diet


Limit refined sugars



Exercise


≥150 min/week moderate intensity



Weight


Target BMI <25 kg/m²



Others


Smoking cessation


Limit alcohol




---


3. Pharmacologic Therapy


A. Statins (First-line)


↓ LDL by 30–60%


Stabilize plaques



High-intensity statins


Atorvastatin 40–80 mg


Rosuvastatin 20–40 mg



Indications


ASCVD → high-intensity


LDL ≥190 → high-intensity


Diabetes (age 40–75) → moderate/high




---


B. Non-Statin Therapies


Ezetimibe


Add if LDL target not achieved with statin



PCSK9 inhibitors


Alirocumab, Evolocumab


For very high-risk or statin intolerance



Bempedoic acid


Alternative in statin intolerance




---


C. Hypertriglyceridemia Treatment


TG 150–499 mg/dL


Lifestyle + statins



TG ≥500 mg/dL (pancreatitis risk)


Fibrates (Fenofibrate)


Omega-3 fatty acids




---


4. LDL Targets (Guideline-Oriented)


Very high risk: <55 mg/dL


High risk: <70 mg/dL


Moderate risk: <100 mg/dL




---


5. Special Situations


Diabetes


Statin for all ≥40 years



Chronic kidney disease


Statin ± ezetimibe



Statin intolerance


Try lower dose / alternate statin


Add non-statin agents




---


6. Monitoring


Lipid profile: baseline, then 4–12 weeks after therapy


Liver enzymes (if indicated)


CK (only if muscle symptoms)




---


7. Key Takeaways


Lifestyle + statin = cornerstone


Treat risk, not just numbers


Add ezetimibe → PCSK9 if targets unmet


Treat high triglycerides to prevent pancreatitis




---


Drmusmanjaved.com


Comments

Popular posts from this blog

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

Learn Echocardiography | Standard Protocol for Performing Comprehensive Echocardiogram | Explained with Images and Videos

  If you are just starting to learn echocardiography, you will find that learning the full echo examination protocol will be immensely useful. The full protocol will provide a solid foundation for your career in echo. I personally found that once I could execute the standard protocol flawlessly, I was able to add and refine additional echo scanning skills while deepening my understanding of the purpose of each echo image. The echo protocol illustrated in this article is the same one we currently use for all our patients in the hospital and meets or exceeds the standards of American Society of Echocardiography (ASE) for an adult echocardiography examination. The protocol presented here is meant as a guideline and does not cover every aspect (such as off axis views) of an echo examination. Also other hospitals will probably have slight variations of this protocol depending on the lab's needs, which is normal. This article's main purpose is to provide a solid foundation for ...